1. Home
  2. CRVL vs TLX Comparison

CRVL vs TLX Comparison

Compare CRVL & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CorVel Corp.

CRVL

CorVel Corp.

SELL

Current Price

$86.46

Market Cap

2.8B

Sector

Finance

ML Signal

SELL

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

SELL

Current Price

$9.27

Market Cap

3.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CRVL
TLX
Founded
1987
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.3B
IPO Year
1995
2024

Fundamental Metrics

Financial Performance
Metric
CRVL
TLX
Price
$86.46
$9.27
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $19.90
AVG Volume (30 Days)
133.7K
★ 320.2K
Earning Date
11-03-2026
10-22-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 16.94
N/A
EPS
★ 1.31
N/A
Revenue
★ $958,527,000.00
N/A
Revenue This Year
N/A
$16.59
Revenue Next Year
N/A
$13.64
P/E Ratio
★ $66.00
$150.33
Revenue Growth
★ 7.03
N/A
52 Week Low
$44.83
$6.28
52 Week High
$89.76
$13.11

Technical Indicators

Market Signals
Indicator
CRVL
TLX
Relative Strength Index (RSI) 64.89 43.03
Support Level $56.81 $8.69
Resistance Level $89.76 $9.70
Average True Range (ATR) 2.75 0.22
MACD -0.18 0.08
Stochastic Oscillator 68.78 43.81

Price Performance

Historical Comparison
CRVL
TLX

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix is a developer of radiopharmaceuticals. Radiopharmaceuticals are specialized drugs containing radioactive isotopes, which are used in both diagnosing and treating cancer. At low doses, these drugs bind to a specific cancer cell and can be visualized through PET imaging. With high doses, they can deliver targeted treatment. Telix has a pipeline of both diagnostics and therapeutics in development. Its pipeline is focused on urologic oncology (prostate, kidney and bladder), neuro-oncology (glioma), musculoskeletal oncology and hematology. Currently, most of the firm's revenue comes from its Illuccix prostate cancer imaging/diagnostic agent.

Share on Social Networks: